Cargando…
First pan-specific vNAR against human TGF-β as a potential therapeutic application: in silico modeling assessment
Immunotherapies based on antibody fragments have been developed and applied to human diseases, describing novel antibody formats. The vNAR domains have a potential therapeutic use related to their unique properties. This work used a non-immunized Heterodontus francisci shark library to obtain a vNAR...
Autores principales: | Burciaga-Flores, Mirna, Márquez-Aguirre, Ana Laura, Dueñas, Salvador, Gasperin-Bulbarela, Jahaziel, Licea-Navarro, Alexei F., Camacho-Villegas, Tanya A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982792/ https://www.ncbi.nlm.nih.gov/pubmed/36869086 http://dx.doi.org/10.1038/s41598-023-30623-x |
Ejemplares similares
-
Intraocular Penetration of a vNAR: In Vivo and In Vitro VEGF(165) Neutralization
por: Camacho-Villegas, Tanya A., et al.
Publicado: (2018) -
Neutralizing Ability of a Single Domain VNAR Antibody: In Vitro Neutralization of SARS-CoV-2 Variants of Concern
por: Valdovino-Navarro, Blanca J., et al.
Publicado: (2022) -
Synthetic libraries of shark vNAR domains with different cysteine numbers within the CDR3
por: Cabanillas-Bernal, Olivia, et al.
Publicado: (2019) -
Allosteric inhibition of Aurora-A kinase by a synthetic vNAR domain
por: Burgess, Selena G., et al.
Publicado: (2016) -
Screening and characterization of inhibitory vNAR targeting nanodisc-assembled influenza M2 proteins
por: Yu, Chuandi, et al.
Publicado: (2022)